उत्पाद विवरण
1. Technical Specifications
| Attribute |
Details |
| Brand Name |
Aggribloc 5 mg Infusion |
| Active Ingredient |
Tirofiban Hydrochloride |
| Strength |
5 mg/100 ml (varies by pack) |
| Dosage Form |
Intravenous Infusion |
| Packaging Size |
Single-use vial/bottle |
| Packaging Type |
Sterile glass vial/bottle |
| Medicine Type |
Allopathic, Antiplatelet Agent |
| Manufactured By |
Sun Pharmaceutical Industries Ltd. (and other manufacturers) |
| Distributed By |
Authorized pharmaceutical distributors |
2. Product Description
Aggribloc 5 mg Infusion contains Tirofiban Hydrochloride, a potent glycoprotein IIb/IIIa receptor antagonist. It prevents platelet aggregation and reduces the risk of clot formation. The infusion is mainly prescribed for acute coronary syndrome (ACS) such as unstable angina and non-ST elevation myocardial infarction (NSTEMI), and is often used during angioplasty (PCI) procedures. It is administered intravenously under hospital supervision along with aspirin and heparin.
3. Product Highlights
| Attribute |
Details |
| Generic Name |
Tirofiban Hydrochloride |
| Dosage Form |
Intravenous infusion |
| Therapeutic Category |
Antiplatelet, Cardiovascular drug |
| Application Area |
ACS management, PCI support |
| Administration |
IV infusion under medical monitoring |
| Storage Conditions |
Store below 25C, protect from light, do not freeze |
4. Therapeutic Uses
5. Side Effects
Common:
-
Minor bleeding (injection site, gums, nosebleeds)
-
Headache, nausea, dizziness
-
Drop in blood pressure
Serious (less common):
-
Major bleeding (GI tract, brain hemorrhage)
-
Thrombocytopenia (low platelet count)
-
Severe allergic reaction (rare)
6. Precautions
-
Strictly for hospital use with continuous monitoring.
-
Contraindications:
-
Active internal bleeding
-
Recent major surgery or trauma
-
History of hemorrhagic stroke
-
Severe uncontrolled hypertension
-
Requires dose adjustment in patients with kidney impairment.
-
Monitor platelet count, hemoglobin, hematocrit regularly.
-
Avoid combination with other strong anticoagulants/antiplatelets unless directed.
Targeted Medical UseAggribloc 5mg Infusion is intended exclusively for adult patients and should only be administered by qualified healthcare professionals. As a prescription-only medication, its usage and dosage must be determined by a doctor in accordance with medical guidelines to ensure optimal safety and effectiveness.
Storage and Handling PrecautionsProper storage is vital to maintaining the quality of Aggribloc 5mg Infusion. Ensure that the product is kept in a cool and dry place, away from direct sunlight or heat sources. Follow the storage instructions on the packaging and use before the expiration date for best results.
FAQs of Aggribloc 5mg Infusion:
Q: How should Aggribloc 5mg Infusion be administered?
A: Aggribloc 5mg Infusion is administered via intravenous injection and should only be given by a doctor or qualified healthcare professional, following the prescribed dosage guidelines.
Q: What are the recommended storage conditions for this medication?
A: Store Aggribloc 5mg Infusion in a cool and dry place, avoiding exposure to heat and humidity to preserve its effectiveness.
Q: When should Aggribloc 5mg Infusion be used?
A: This product should be used strictly according to a doctors instructions and only when recommended for the patients specific medical condition.
Q: Where can Aggribloc 5mg Infusion be sourced from in India?
A: Aggribloc 5mg Infusion is distributed throughout India by authorized distributors, exporters, suppliers, traders, and wholesalers.
Q: What is the process for using Aggribloc 5mg Infusion?
A: The process involves a doctor assessing your medical needs, determining the dosage, and administering the infusion under monitored medical conditions.
Q: What are the key benefits of using Aggribloc 5mg Infusion?
A: When used correctly, Aggribloc 5mg Infusion provides targeted therapeutic benefits as directed by your doctor, supporting optimal outcomes for specific adult health conditions.